{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:30:59Z","timestamp":1793662259685,"version":"4.5.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA80058"],"award-info":[{"award-number":["P01CA80058"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA170702"],"award-info":[{"award-number":["R01CA170702"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01 OHO11328"],"award-info":[{"award-number":["U01 OHO11328"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammatory Breast Cancer (IBC) is a highly aggressive malignancy with distinct clinical and histopathological features whose molecular basis is unresolved. Here we describe a human IBC cell line, A3250, that recapitulates key IBC features in a mouse xenograft model, including skin erythema, diffuse tumor growth, dermal lymphatic invasion, and extensive metastases. A3250 cells express very high levels of the CCL2 chemokine and induce tumors enriched in macrophages. CCL2 knockdown leads to a striking reduction in macrophage densities, tumor proliferation, skin erythema, and metastasis. These results establish IBC-derived CCL2 as a key factor driving macrophage expansion, and indirectly tumor growth, with transcriptomic analysis demonstrating the activation of multiple inflammatory pathways. Finally, primary human IBCs exhibit macrophage infiltration and an enriched macrophage RNA signature. Thus, this human IBC model provides insight into the distinctive biology of IBC, and highlights potential therapeutic approaches to this deadly disease.<\/jats:p>","DOI":"10.1038\/s41467-021-27108-8","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T06:08:02Z","timestamp":1637820482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6750-5159","authenticated-orcid":false,"given":"Anita","family":"Rogic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0517-6542","authenticated-orcid":false,"given":"Ila","family":"Pant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8231-3032","authenticated-orcid":false,"given":"Luca","family":"Grumolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9127-1735","authenticated-orcid":false,"given":"Ruben","family":"Fernandez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvendu","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5773-3382","authenticated-orcid":false,"given":"Aaron","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9843-7427","authenticated-orcid":false,"given":"Shabnam","family":"Jaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Sachidanandam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-8085","authenticated-orcid":false,"given":"Guray","family":"Akturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1291-2897","authenticated-orcid":false,"given":"Rosa","family":"Karlic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1583-6487","authenticated-orcid":false,"given":"Mihaela","family":"Skobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4643-0474","authenticated-orcid":false,"given":"Stuart A.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"27108_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3322\/caac.20082","volume":"60","author":"FM Robertson","year":"2010","unstructured":"Robertson, F. M. et al. Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J. Clin. 60, 351\u2013375 (2010).","journal-title":"CA Cancer J. Clin."},{"key":"27108_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10549-015-3436-x","volume":"152","author":"TM Fouad","year":"2015","unstructured":"Fouad, T. M. et al. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Res. Treat. 152, 407\u2013416 (2015).","journal-title":"Breast Cancer Res. Treat."},{"key":"27108_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clbc.2014.05.005","volume":"15","author":"JM Matro","year":"2015","unstructured":"Matro, J. M. et al. Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome. Clin. Breast Cancer 15, 1\u20137 (2015).","journal-title":"Clin. Breast Cancer"},{"key":"27108_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-018-0010-y","volume":"18","author":"B Lim","year":"2018","unstructured":"Lim, B., Woodward, W. A., Wang, X., Reuben, J. M. & Ueno, N. T. Inflammatory breast cancer biology: the tumour microenvironment is key. Nat. Rev. Cancer 18, 485\u2013499 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"27108_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-019-0842-y","volume":"21","author":"JM Rosenbluth","year":"2019","unstructured":"Rosenbluth, J. M. & Overmoyer, B. A. Inflammatory breast cancer: a separate entity. Curr. Oncol. Rep. 21, 86 (2019).","journal-title":"Curr. Oncol. Rep."},{"key":"27108_CR6","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1016\/S1470-2045(17)30192-4","volume":"18","author":"TM Fouad","year":"2017","unstructured":"Fouad, T. M. et al. Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system. Lancet Oncol. 18, e228\u2013e232 (2017).","journal-title":"Lancet Oncol."},{"key":"27108_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3579","volume":"15","author":"H Masuda","year":"2013","unstructured":"Masuda, H. et al. Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers. Breast Cancer Res. 15, R112 (2013).","journal-title":"Breast Cancer Res."},{"key":"27108_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.breast.2014.06.008","volume":"23","author":"F Bertucci","year":"2014","unstructured":"Bertucci, F. et al. Genomic profiling of inflammatory breast cancer: a review. Breast 23, 538\u2013545 (2014).","journal-title":"Breast"},{"key":"27108_CR9","first-page":"5079","volume":"59","author":"ML Alpaugh","year":"1999","unstructured":"Alpaugh, M. L., Tomlinson, J. S., Shao, Z. M. & Barsky, S. H. A novel human xenograft model of inflammatory breast cancer. Cancer Res. 59, 5079\u20135084 (1999).","journal-title":"Cancer Res."},{"key":"27108_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/path.1515","volume":"202","author":"E Charafe-Jauffret","year":"2004","unstructured":"Charafe-Jauffret, E. et al. Immunophenotypic analysis of inflammatory breast cancers: identification of an \u2018inflammatory signature\u2019. J. Pathol. 202, 265\u2013273 (2004).","journal-title":"J. Pathol."},{"key":"27108_CR11","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1002\/cncr.25173","volume":"116","author":"WA Woodward","year":"2010","unstructured":"Woodward, W. A., Debeb, B. G., Xu, W. & Buchholz, T. A. Overcoming radiation resistance in inflammatory breast cancer. Cancer 116, 2840\u20132845 (2010).","journal-title":"Cancer"},{"key":"27108_CR12","doi-asserted-by":"crossref","unstructured":"Lacerda, L. & Woodward, W. A. In Inflammatory Breast Cancer: An Update (eds Ueno, N. T. & Cristofanilli, M.) 139\u2013150 (Springer Netherlands, 2012).","DOI":"10.1007\/978-94-007-3907-9_13"},{"key":"27108_CR13","doi-asserted-by":"publisher","first-page":"872743","DOI":"10.1155\/2013\/872743","volume":"2013","author":"N Barnabas","year":"2013","unstructured":"Barnabas, N. & Cohen, D. Phenotypic and molecular characterization of MCF10DCIS and SUM breast cancer cell lines. Int. J. Breast Cancer 2013, 872743 (2013).","journal-title":"Int. J. Breast Cancer"},{"key":"27108_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10549-013-2600-4","volume":"140","author":"SV Fernandez","year":"2013","unstructured":"Fernandez, S. V. et al. Inflammatory breast cancer (IBC): clues for targeted therapies. Breast Cancer Res Treat. 140, 23\u201333 (2013).","journal-title":"Breast Cancer Res Treat."},{"key":"27108_CR15","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","volume":"51","author":"DJ Giard","year":"1973","unstructured":"Giard, D. J. et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51, 1417\u20131423 (1973).","journal-title":"J. Natl. Cancer Inst."},{"key":"27108_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2834","volume":"13","author":"B Keam","year":"2011","unstructured":"Keam, B. et al. Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis. Breast Cancer Res. 13, R22 (2011).","journal-title":"Breast Cancer Res."},{"key":"27108_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"27108_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8367","volume":"6","author":"Y Murakawa","year":"2015","unstructured":"Murakawa, Y. et al. RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK\/NF-\u03baB pathway. Nat. Commun. 6, 7367 (2015).","journal-title":"Nat. Commun."},{"key":"27108_CR19","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ejso.2018.04.001","volume":"44","author":"G Cserni","year":"2018","unstructured":"Cserni, G., Charafe-Jauffret, E. & van Diest, P. J. Inflammatory breast cancer: The pathologists\u2019 perspective. Eur. J. Surg. Oncol. 44, 1128\u20131134 (2018).","journal-title":"Eur. J. Surg. Oncol."},{"key":"27108_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar, V., Patel, S., Tcyganov, E. & Gabrilovich, D. I. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 37, 208\u2013220 (2016).","journal-title":"Trends Immunol."},{"key":"27108_CR21","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41556-019-0373-7","volume":"21","author":"IS Kim","year":"2019","unstructured":"Kim, I. S. et al. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nat. Cell Biol. 21, 1113\u20131126 (2019).","journal-title":"Nat. Cell Biol."},{"key":"27108_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3389\/fimmu.2019.00819","volume":"10","author":"G Upadhyay","year":"2019","unstructured":"Upadhyay, G. Emerging role of lymphocyte antigen-6 family of genes in cancer and immune cells. Front Immunol. 10, 819 (2019).","journal-title":"Front Immunol."},{"key":"27108_CR23","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","volume":"285","author":"CE Hughes","year":"2018","unstructured":"Hughes, C. E. & Nibbs, R. J. B. A guide to chemokines and their receptors. FEBS J. 285, 2944\u20132971 (2018).","journal-title":"FEBS J."},{"key":"27108_CR24","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/sj.bjc.6603967","volume":"97","author":"S Van Laere","year":"2007","unstructured":"Van Laere, S. et al. Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis. Br. J. cancer 97, 1165\u20131174 (2007).","journal-title":"Br. J. cancer"},{"key":"27108_CR25","doi-asserted-by":"publisher","first-page":"e12616","DOI":"10.1371\/journal.pone.0012616","volume":"5","author":"I Van Der Auwera","year":"2010","unstructured":"Van Der Auwera, I. et al. Array-Based DNA methylation profiling for breast cancer subtype discrimination. PLoS ONE 5, e12616 (2010).","journal-title":"PLoS ONE"},{"key":"27108_CR26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10549-010-1280-6","volume":"125","author":"T Iwamoto","year":"2011","unstructured":"Iwamoto, T. et al. Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer. Breast Cancer Res. Treat. 125, 785\u2013795 (2011).","journal-title":"Breast Cancer Res. Treat."},{"key":"27108_CR27","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1084\/jem.20141836","volume":"212","author":"T Kitamura","year":"2015","unstructured":"Kitamura, T. et al. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J. Exp. Med. 212, 1043\u20131059 (2015).","journal-title":"J. Exp. Med."},{"key":"27108_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","volume":"40","author":"P Pathria","year":"2019","unstructured":"Pathria, P., Louis, T. L. & Varner, J. A. Targeting tumor-associated macrophages in cancer. Trends Immunol. 40, 310\u2013327 (2019).","journal-title":"Trends Immunol."},{"key":"27108_CR29","first-page":"4687","volume":"9","author":"BJ Rollins","year":"1989","unstructured":"Rollins, B. J., Stier, P., Ernst, T. & Wong, G. G. The human homolog of the JE gene encodes a monocyte secretory protein. Mol. Cell Biol. 9, 4687\u20134695 (1989).","journal-title":"Mol. Cell Biol."},{"key":"27108_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","volume":"35","author":"L Cassetta","year":"2019","unstructured":"Cassetta, L. et al. Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets. Cancer Cell 35, 588\u2013602.e510 (2019).","journal-title":"Cancer Cell"},{"key":"27108_CR31","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.7150\/jca.31176","volume":"10","author":"GR Devi","year":"2019","unstructured":"Devi, G. R. et al. Perspectives on inflammatory breast cancer (IBC) research, clinical management and community engagement from the Duke IBC consortium. J. Cancer 10, 3344\u20133351 (2019).","journal-title":"J. Cancer"},{"key":"27108_CR32","unstructured":"Haagensen, C. D. & Harris, J. R. Diseases of the Breast. (W.B. Saunders, 1971)."},{"key":"27108_CR33","doi-asserted-by":"crossref","unstructured":"Fouad, T. M., Kogawa, T., Reuben, J. M. & Ueno, N. T. In Inflammation and Cancer (eds Aggarwal, B. B., Sung, B. & Gupta, S. C.) 53\u201373 (Springer Basel, 2014).","DOI":"10.1007\/978-3-0348-0837-8_3"},{"key":"27108_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fonc.2014.00246","volume":"4","author":"HT Mohamed","year":"2014","unstructured":"Mohamed, H. T. et al. Inflammatory breast cancer: high incidence of detection of mixed human cytomegalovirus genotypes associated with disease pathogenesis. Front Oncol. 4, 246 (2014).","journal-title":"Front Oncol."},{"key":"27108_CR35","doi-asserted-by":"publisher","first-page":"e0204513","DOI":"10.1371\/journal.pone.0204513","volume":"13","author":"K Harano","year":"2018","unstructured":"Harano, K. et al. Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype. PLoS One 13, e0204513 (2018).","journal-title":"PLoS One"},{"key":"27108_CR36","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1158\/0008-5472.CAN-17-2158","volume":"79","author":"A Valeta-Magara","year":"2019","unstructured":"Valeta-Magara, A. et al. Inflammatory breast cancer promotes development of M2 tumor-associated macrophages and cancer mesenchymal cells through a complex chemokine network. Cancer Res. 79, 3360\u20133371 (2019).","journal-title":"Cancer Res."},{"key":"27108_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10549-018-4835-6","volume":"171","author":"JP Reddy","year":"2018","unstructured":"Reddy, J. P. et al. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer. Breast Cancer Res. Treat. 171, 283\u2013293 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"27108_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.biocel.2013.11.015","volume":"46","author":"MM Mohamed","year":"2014","unstructured":"Mohamed, M. M. et al. Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. Int. J. Biochem Cell Biol. 46, 138\u2013147 (2014).","journal-title":"Int. J. Biochem Cell Biol."},{"key":"27108_CR39","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ccr.2012.02.017","volume":"21","author":"ES Nakasone","year":"2012","unstructured":"Nakasone, E. S. et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21, 488\u2013503 (2012).","journal-title":"Cancer Cell"},{"key":"27108_CR40","doi-asserted-by":"publisher","first-page":"14979","DOI":"10.1038\/ncomms14979","volume":"8","author":"M Ouzounova","year":"2017","unstructured":"Ouzounova, M. et al. Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade. Nat. Commun. 8, 14979\u201314979 (2017).","journal-title":"Nat. Commun."},{"key":"27108_CR41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"B-Z Qian","year":"2011","unstructured":"Qian, B.-Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222\u2013225 (2011).","journal-title":"Nature"},{"key":"27108_CR42","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1158\/0008-5472.CAN-06-1823","volume":"67","author":"JB Wyckoff","year":"2007","unstructured":"Wyckoff, J. B. et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67, 2649\u20132656 (2007).","journal-title":"Cancer Res."},{"key":"27108_CR43","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1158\/0008-5472.CAN-04-1853","volume":"65","author":"S Goswami","year":"2005","unstructured":"Goswami, S. et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1\/epidermal growth factor paracrine loop. Cancer Res. 65, 5278\u20135283 (2005).","journal-title":"Cancer Res"},{"key":"27108_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","volume":"21","author":"I Keklikoglou","year":"2019","unstructured":"Keklikoglou, I. et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat. Cell Biol. 21, 190\u2013202 (2019).","journal-title":"Nat. Cell Biol."},{"key":"27108_CR45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ccr.2011.03.010","volume":"19","author":"S Vijayakumar","year":"2011","unstructured":"Vijayakumar, S. et al. High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF\/beta-catenin target gene, CDC25A. Cancer Cell 19, 601\u2013612 (2011).","journal-title":"Cancer Cell"},{"key":"27108_CR46","doi-asserted-by":"publisher","first-page":"e1003603","DOI":"10.1371\/journal.pgen.1003603","volume":"9","author":"L Grumolato","year":"2013","unstructured":"Grumolato, L. et al. beta-Catenin-independent activation of TCF1\/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors. PLoS Genet. 9, e1003603 (2013).","journal-title":"PLoS Genet."},{"key":"27108_CR47","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L","volume":"78","author":"AF Gazdar","year":"1998","unstructured":"Gazdar, A. F. et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer 78, 766\u2013774 (1998).","journal-title":"Int. J. Cancer"},{"key":"27108_CR48","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1002\/ijc.27931","volume":"132","author":"A Capes-Davis","year":"2013","unstructured":"Capes-Davis, A. et al. Match criteria for human cell line authentication: where do we draw the line? Int J. Cancer 132, 2510\u20132519 (2013).","journal-title":"Int J. Cancer"},{"key":"27108_CR49","first-page":"E7321","volume":"114","author":"W Li","year":"2017","unstructured":"Li, W., Germain, R. N. & Gerner, M. Y. Multiplex, quantitative cellular analysis in large tissue volumes with clearing-enhanced 3D microscopy (Ce3D). Proc. Natl. Acad. Sci. USA 114, E7321\u2013E7330 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"27108_CR50","doi-asserted-by":"publisher","first-page":"aaf6925","DOI":"10.1126\/sciimmunol.aaf6925","volume":"1","author":"R Remark","year":"2016","unstructured":"Remark, R. et al. In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide. Sci. Immunol. 1, aaf6925 (2016).","journal-title":"Sci. Immunol."},{"key":"27108_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/978-1-4939-9773-2_23","volume":"2055","author":"G Akturk","year":"2020","unstructured":"Akturk, G., Sweeney, R., Remark, R., Merad, M. & Gnjatic, S. Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): multiplexed chromogenic IHC assay for high-dimensional tissue analysis. Methods Mol. Biol. 2055, 497\u2013519 (2020).","journal-title":"Methods Mol. Biol."},{"key":"27108_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/84643","volume":"7","author":"M Skobe","year":"2001","unstructured":"Skobe, M. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7, 192\u2013198 (2001).","journal-title":"Nat. Med."},{"key":"27108_CR53","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","volume":"46","author":"E Afgan","year":"2018","unstructured":"Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res 46, W537\u2013W544 (2018).","journal-title":"Nucleic Acids Res"},{"key":"27108_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"27108_CR55","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"27108_CR56","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"Mccarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288\u20134297 (2012).","journal-title":"Nucleic Acids Res."},{"key":"27108_CR57","doi-asserted-by":"publisher","first-page":"e17490","DOI":"10.1371\/journal.pone.0017490","volume":"6","author":"Z Sun","year":"2011","unstructured":"Sun, Z. et al. Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing. PLoS One 6, e17490 (2011).","journal-title":"PLoS One"},{"key":"27108_CR58","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"27108_CR59","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer, A., Green, J., Pollard, J. Jr & Tugendreich, S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"},{"key":"27108_CR60","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"27108_CR61","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"27108_CR62","doi-asserted-by":"crossref","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology 15 (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"27108_CR63","doi-asserted-by":"crossref","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res. 41 (2013).","DOI":"10.1093\/nar\/gks1193"},{"key":"27108_CR64","doi-asserted-by":"publisher","first-page":"D19","DOI":"10.1093\/nar\/gkq1019","volume":"39","author":"R Leinonen","year":"2011","unstructured":"Leinonen, R., Sugawara, H. & Shumway, M., International Nucleotide Sequence Database, C. The sequence read archive. Nucleic Acids Res. 39, D19\u2013D21 (2011).","journal-title":"Nucleic Acids Res."},{"key":"27108_CR65","doi-asserted-by":"publisher","first-page":"D246","DOI":"10.1093\/nar\/gkx1158","volume":"46","author":"I Papatheodorou","year":"2018","unstructured":"Papatheodorou, I. et al. Expression atlas: gene and protein expression across multiple studies and organisms. Nucleic Acids Res 46, D246\u2013D251 (2018).","journal-title":"Nucleic Acids Res"},{"key":"27108_CR66","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1158\/1078-0432.CCR-08-1077","volume":"14","author":"S Van Laere","year":"2008","unstructured":"Van Laere, S. et al. Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer. Clin. Cancer Res. 14, 7452\u20137460 (2008).","journal-title":"Clin. Cancer Res."},{"key":"27108_CR67","first-page":"3","volume":"2200","author":"J Wu","year":"2012","unstructured":"Wu, J., Irizarry, R., MacDonald, J. & Gentry, J. Gcrma: background adjustment using sequence information. R. Package Version 2200, 3\u201310 (2012).","journal-title":"R. Package Version"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27108-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27108-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27108-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T13:46:20Z","timestamp":1669988780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27108-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["27108"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27108-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741262506.793592304","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"assertion":[{"value":"1 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6889"}}